Streetbeat News

Regulatory

CRLBF

CURLF

Cresco Labs, rated 'Overweight' by Zuanic & Associates, is positioned to benefit from regulatory changes and market growth in Ohio, Florida, and Pennsylvania. Despite trading at a discount, its financial stability and strategic positioning present a potential opportunity for investors.

Portfolio Pulse from Nicolás Jose Rodriguez

September 09, 2024 | 6:29 pm

EGIO

RLAY

SINT

U.S. stocks rose with the S&P 500 gaining around 1%. Relay Therapeutics shares spiked 63% after positive interim data for its breast cancer treatment. Sintx Technologies shares surged 87% following a patent allowance. Edgio shares dropped 80% due to financial restructuring.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 6:16 pm

AZN

Datopotamab Deruxtecan, a drug in a Phase III trial for advanced nonsquamous NSCLC, shows a median overall survival of 14.6 months. The results will be presented at the 2024 World Conference on Lung Cancer.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 5:51 pm

META

SPY

VGK

Elon Musk may be summoned by the UK parliament due to his role in X, raising potential regulatory concerns. This development could impact companies like Meta, which operates in similar spaces, and broader market indices like SPY and VGK.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 5:30 pm

MRNA

Moderna's shares are rising following the approval of a Drug Establishment License for its manufacturing facility in Laval, Quebec, by Health Canada.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 5:03 pm

BTCUSD

A Bernstein report suggests that the 2024 U.S. presidential election could significantly impact Bitcoin's price. A Trump victory might propel Bitcoin to $80,000-$90,000, while a Harris win could see it drop to $30,000-$40,000. The report highlights the crypto industry's warmer reception from the Trump camp and the challenging regulatory environment.

Portfolio Pulse from Khyathi Dalal

September 09, 2024 | 5:01 pm

BNTX

MRNA

PFE

Moderna's stock rose after its Laval, Quebec facility received a Drug Establishment License from Health Canada, allowing it to produce mRNA vaccines domestically. This milestone supports Moderna's strategic partnership with Canada and enhances its global manufacturing footprint.

Portfolio Pulse from Vandana Singh

September 09, 2024 | 5:00 pm

IMVT

ROIV

Immunovant, a Roivant Sciences company, reported positive results from its Phase 2a trial of batoclimab for Graves' Disease, showing significant IgG reduction and response rates. The company plans to start a pivotal trial by the end of the year. Roivant's stock rose, while Immunovant's slightly declined.

Portfolio Pulse from Vandana Singh

September 09, 2024 | 4:54 pm

ETHUSD

Ether.fi is launching a blockchain-based credit card, Ether.fi Cash, in partnership with Scroll, an Ethereum Layer-2 network. The card allows users to spend fiat while using crypto as collateral, offering 3% cash-back and crypto-based rewards. Initially available internally, it will ship to pre-order customers on Sep. 16, but won't be available in the U.S. due to regulatory concerns.

Portfolio Pulse from Murtuza Merchant

September 09, 2024 | 3:53 pm

SPY

The U.S. SEC has approved a new quality control standard, QC 1000, for public accounting firms, aiming to enhance audit quality and investor protection. This standard requires firms to identify risks and implement a quality control system, with annual evaluations and external quality control functions for larger firms.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 3:52 pm